CPMP/ 811/ 02 sammenlignet med 0, 6%) og seks gange større end for andre statiner (2, 0% sammenlignet med 0, 35%).
This is particularly marked with the 0.8mg formulation, for which the incidence of rhabdomyolysis is between 4 and 10 fold greater than that of the other statins, though the CPMP/ 8